GDNA News and Press, Goldman Sachs Human Evolution ETF

An observational study involving COVID-19 patients treated at New York-Presbyterian Hospital-Columbia University Irving Medical Center did not show a treatment benefit from the use of malaria drug hydroxychloroquine. The results were just published in the New England Journal of Medicine ....

By Ansh Chaudhary The ETF Deathwatch decreased in size in March. Sixteen exchange-traded products ("ETPs") were added to the list, and 54 funds were removed. Thirty-three of those funds were removed due to increased health and 21 were due to asset managers closing their funds. The low numb...

In a statement , the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart rhythm side effects. More news on: Tekla World Healthcare Fund, BlackRock Health Science...

Former FDA Commissioner Scott Gottlieb, M.D. is joining the growing chorus of experts who believe that the actual number of COVID-19 infections in the U.S. is substantially higher than reported, as much as 20 times higher he says. More news on: Tekla World Healthcare Fund, BlackRock Health...

In a statement , the American Association of Clinical Chemistry (AACC), a clinical laboratory industry group, says the scarcity of essential gear, including sample collection (nasal swabs) and test components and personal protective equipment, will continue to hamper the nation's labs in ex...

States across the U.S. are instituting measures to prevent hoarding of malaria drugs hydroxychloroquine and chloroquine in an effort to maintain supply amid acute demand from pharmacies and COVID-19 patients. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The...

New York Governor Andrew Cuomo is warning that the state is still not ready to handle the peak number COVID-19 cases, expected in the next seven days or so. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Wellness Rx Trust, Healthc...

Addressing the "urgent and immediate need" for donated blood during the COVID-19 pandemic, the FDA has issued new guidance relaxing its recommendations for acceptable donations. More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Welln...

In a note, UBS regards the republished results from one of the first randomized trials evaluating malaria drug hydroxychloroquine (HCQ) in COVID-19 patients as "inconclusive." More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Well...

The FDA announces its Coronavirus Treatment Acceleration Program that, it says, leverages every tool at its disposal (e.g., cutting red tape, redeploying staff) to speed up the development of therapies to treat COVID-19 infection. Key points: More news on: Tekla World Healthcare Fund, Bl...